Arete Wealth Advisors’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,683
Closed -$101K 773
2023
Q3
$101K Sell
3,683
-244
-6% -$7.81K 0.02% 468
2023
Q2
$137K Hold
3,927
0.01% 618
2023
Q1
$138K Buy
+3,927
New +$141K 0.01% 595
2022
Q4
Sell
-4,285
Closed -$145K 718
2022
Q3
$145K Buy
+4,285
New +$159K 0.01% 530
2022
Q2
Sell
-4,688
Closed -$204K 575
2022
Q1
$204K Buy
4,688
+389
+9% +$16.8K 0.02% 478
2021
Q4
$213K Buy
+4,299
New +$223K 0.02% 461

Other funds holding HEAL

Arete Wealth Advisors's HEAL Position: Q4 2023 in Review

Arete Wealth Advisors sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q4 2023, closing a stake of 3,683 shares — an estimated $101K sold.

Arete Wealth Advisors first reported a position in HEAL in Q4 2021 and held it in 6 quarters. The position peaked at $213K in Q4 2021. 43 funds tracked by Wall St. Rank hold HEAL as of Q4 2023.

  • Arete Wealth Advisors reported no remaining Global X Funds Global X HealthTech ETF position as of Q4 2023 after selling out during the quarter.
  • Arete Wealth Advisors sold 3,683 Global X Funds Global X HealthTech ETF shares in Q4 2023, an estimated $101K.
  • Arete Wealth Advisors first reported a position in Global X Funds Global X HealthTech ETF in Q4 2021 and held it in 6 quarters.
  • Arete Wealth Advisors's Global X Funds Global X HealthTech ETF position peaked at $213K in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q4 2023.

Based on Arete Wealth Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.